NCT04637724

Brief Summary

For the present study, Investigators will examine the efficacy of active prefrontal anodal tDCS versus placebo (sham) interventions to treat WM dysfunction in schizophrenia. Investigators selected the prefrontal stimulation modality that proved most effective in enhancing high-load WM performance in single dose stimulation in healthy participants . The study employs a multi-stimulation approach, with 2 sessions per day for 5 consecutive days in the active treatment group (n=15) compared to a group that receives only sham stimulation (n=15). This preliminary approach is based upon findings of a recent study applying cathodal tDCS stimulation over left temporoparietal cortex (with left prefrontal anodal stimulation) for the treatment of persistent auditory hallucinations in schizophrenia. In a a recent study clinical benefits were maintained for at least 3 months following stimulation. In the present study, in addition to clinical outcome, researchers will evaluate whether similar improvement can be obtained with WM, EEG activity, and functional outcome (e.g., discharged from hospitalization following significant improvement or remission).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at below P25 for not_applicable schizophrenia

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 29, 2019

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

November 11, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 20, 2020

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2023

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2023

Completed
Last Updated

September 25, 2023

Status Verified

September 1, 2023

Enrollment Period

3.8 years

First QC Date

November 11, 2020

Last Update Submit

September 21, 2023

Conditions

Keywords

Working memorySchizophrenia symtom severity,Prefrontal tDCSEvent related EEG

Outcome Measures

Primary Outcomes (3)

  • change in Positivie and Negative Syndrome Scale (PANSS, minimum score = 30, maximum score = 350, higher score indicate incresed ilness severity, lower scores indicate lower ilness severity) scores from baseline to post-tDCS intervention

    change in total scores of the Positive and negative syndrome scale for Scizophrenia

    Immediately after 10-day tDCS-intervention

  • change in working memory accuracy scores from baseline to post-tDCS intervention

    change in verbal working memory accuracy (scores range from 0 to 126 correct responses)

    Immediately after 10-day tDCS intervention

  • change in working memory reaction times from baseline to post-tDCS intervention

    change in mean reaction times of correct rsponses (i.e., hits) (measures in millisecods range from 400 to 2000 msec)

    Immediately after 10-day tDCS intervention

Secondary Outcomes (3)

  • change in Mismatch neagtivity (MMN) event related potentials from baseline to post-tDCS intervention

    Imediatly after after 10-dat tDCS intervention

  • change from baseline to post-tDCS intervention in Induced EEG theta power folowing verbal command

    Immediatly after tDCS intervention

  • change from baseline to post-tDCS intervention in Induced EEG alpha power folowing verbal command

    Immediatly after tDCS intervention

Study Arms (2)

active tDCS

EXPERIMENTAL

active prefrotal tDCS: 20 mins pes tDCS session, twice a day for 5 days. Total of 10 ative tDCS sessions.

Device: transcranial direct current stimulation (tDCS)

Sham tDCS

SHAM COMPARATOR

Sham prefrontal tDCS: sham stimulation 20 mins per session, twice a day for 5 days. Total of 10 sham stimulation sessions

Device: transcranial direct current stimulation (tDCS)

Interventions

10 sessions of Anodal tDCS of the dorsolateral prefrontal cortex over a period of 5 consecutive days (two session a day). Each session includes the placement of two tDCS electrodes (anodal at left prefrontal area and cathodal above the vertex) and 20 mins of anodal prefrontal stimulation. The tDCS session is received two time a day with a 3-5 hours interveal betwen sessions.

Also known as: Prefrontal tDCS
Sham tDCSactive tDCS

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 18-75
  • Primary diagnosis of DSM-IV schizophrenia (including schizoaffective disorder)
  • Right handed
  • Under stable doses of antipsychotic medication for ≥4 weeks
  • Normal vision by self report and physical exam
  • Use of effective method of birth control for women of childbearing capacity
  • Willing/capacity to provide informed consent
  • Outpatients or volunteering inpatients or involuntary patients with consent of legal guardian.

You may not qualify if:

  • Current or past history of substance dependence or abuse (excluding nicotine)
  • Other current Axis I disorders
  • History of seizure, epilepsy in self or first degree relatives, stoke, brain surgery, head injury, intracranial metal implants, known structural brain lesion, devices that may be affected by tDCS (pacemaker, medication pump, cochlear implant, implanted brain stimulator)
  • Frequent and persistent migraines
  • History of adverse reaction to neurostimulation
  • Participation in study of investigational medication within 6 weeks
  • Pregnancy
  • Women who are breast-feeding
  • Current significant laboratory abnormality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herzog Medical Center

Jerusalem, 91035, Israel

Location

Related Publications (3)

  • Brunelin J, Mondino M, Gassab L, Haesebaert F, Gaha L, Suaud-Chagny MF, Saoud M, Mechri A, Poulet E. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry. 2012 Jul;169(7):719-24. doi: 10.1176/appi.ajp.2012.11071091.

    PMID: 22581236BACKGROUND
  • Meiron O, Yaniv A, Rozenberg S, David J. Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia. Expert Rev Neurother. 2024 Feb;24(2):217-226. doi: 10.1080/14737175.2023.2294150. Epub 2024 Feb 6.

  • Meiron O, David J, Yaniv A. Left prefrontal transcranial direct-current stimulation reduces symptom-severity and acutely enhances working memory in schizophrenia. Neurosci Lett. 2021 Jun 11;755:135912. doi: 10.1016/j.neulet.2021.135912. Epub 2021 Apr 21.

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Alex Borochov, MD

    Herzog Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Active tDCS versus Sham tDCS intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of Non-invasive Brain Stimulation Clinic

Study Record Dates

First Submitted

November 11, 2020

First Posted

November 20, 2020

Study Start

November 29, 2019

Primary Completion

August 30, 2023

Study Completion

September 10, 2023

Last Updated

September 25, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

non personal coded data indicating the participants change in working memory scores, change in psychosis severiry PANSS scores, and change in MMN amplitudes: comparing active tDCS group versus shham-tDCS group

Locations